This is in contrast with a previous study showing that loss of AMPKα2 exaggerated pressure overload-induced cardiac remodeling indicating AMPK as a negative regulator of cardiac hypertrophy [44]. This evidence concerns the gene PRKAA1 and cardiac hypertrophy.